Navigation Links
IPC The Hospitalist Company Acquires Texas Inpatient Services
Date:6/30/2008

Expands presence in the Dallas-Fort Worth market

NORTH HOLLYWOOD, Calif., June 30 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national physician group practice company, announced today that it has acquired Texas Inpatient Services (T.I.P.S.). The acquisition expands IPC's established presence in the Dallas-Fort Worth market.

Adam Singer, M.D., Chairman and CEO of IPC, said, "The acquisition of T.I.P.S. continues to strengthen IPC's position in this important market and sets the stage for continued future growth. We are excited to expand upon T.I.P.S.' established market position, built over its ten-year history, and power it forward with IPC's infrastructure and technology."

Dallas-based T.I.P.S. currently has seven hospitalists covering several local hospitals, plus a number of subacute care facilities in Dallas and nearby suburbs.

Vivek Sastry, M.D., T.I.P.S. Founder and President, stated, "IPC's business and administrative support, especially the IPC-Link (R) technology, will boost our capabilities in key areas such as billing, collections and recruiting, while we remain committed to delivering high quality patient care." Dr. Sastry will remain with IPC as a practice group leader.

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers ma
'/>"/>

SOURCE IPC The Hospitalist Company, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Benefits of hospitalist care confirmed in new study
2. Hospitalist Physicians Help Shorten Patient Stays
3. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
4. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
5. IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters Over-Allotment Option
6. IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results
7. IPC The Hospitalist Company Announces Board of Director Member Changes
8. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
9. IPC The Hospitalist Company Sets 2008 Annual Meeting Date
10. IPC The Hospitalist Company Added to Russell 2000 Index
11. IPC The Hospitalist Company, Inc. to Report First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... HAPPYneuron,s most popular an...the iPhone and iPod Touch. , ... HAPPYneuron,s most popular and addictive game, Sp...Touch. Split Words is designed to help banish that...litWords iPhone brain game challenges the brain ...
(Date:11/20/2009)... , Pioneering Neurologist Closer to Understandi.... 20 Dr. Jeremy Schmahm...ool and neurologist at the Massachusetts General H...nted his laboratory,s research on the new field of...MINDlink Foundation. ,, Dr. Schmahmann is an aw...
(Date:11/20/2009)... , QUINCY, Mass., Nov. 20 Follo...rmarket Company removed from sale Shedd,s Country ...ice and Shedd,s Country Crock ® Side Dishes D...te allergen. ,, The following code dates and U...74; Side Dishes DELUXE Cheddar Broccoli Rice 21 oz...
(Date:11/20/2009)... , ST. LOUIS, Nov. 20 /PRNewswire-FirstCall/...ounced that it will present at the Bank of America...December 2-3, 2009, at the Crowne Plaza Hotel Time...ent Wednesday, December 2nd at 8:30 a.m. Eastern T...cess a live, audio webcast of Centene,s presentati...
(Date:11/20/2009)... , NEW YORK, Nov. 20 /PRNewswire-FirstCall...unced that it will broadcast Doctor Radio Repor...s , an in-depth special hosted by veteran journali...com/cgi-bin/prnh/20080819/NYTU044LOGO ) ,, Doc...w About Mammograms will air November 21 live at...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...for the development of muscles.Da-Zhi Wang and oth... at Chapel Hill // said that the genes are among a... worm 12 years ago. Only in the past few years...appeared in the latest online edition of the journ...
...ni pharmaceutical companies are keen to enhance bu...nment // to relax the stringent visa norms. Pa...and raw materials provided by the Chinese, apart f...sman for the Pakistan Pharmaceutical Manufacturers...
... Research Center has reported that maintaining the...reduce the risk // of cardiovascular disease. The...he blood glucose level of their patients less than...the last few months, the test measures the amount ...
...ed in his recent article that having induced abort...Dr. Brind has compiled data from recent studies of...rnal of American Physicians and Surgeons. Pr...ncrease the risk of developing breast cancer and e...
... increased risk of developing eye problems. A revi...and Zohar Habot-Wilner // , Goldschleger Eye Insti... reviews and found that risk of developing eye pro... found that obese people have high risk of develop...
...l can do to people. High-fat diets cause many pati...g at food labels // to know what they consume. ...r for consumers to avoid trans fats, which plug ar...o vegetable oils to improve shelf life. If a produ...
Other Medicine News:Health News:Pakistan drug companies seek trade ties with India 2Health News:Food labels to include information on trans fats in US 2Health News:Food labels to include information on trans fats in US 3
(Date:11/20/2009)...ire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ...ief Executive Officer, and Greg Browne, Chief Fina...er Jaffray Health Care Conference in New York on W...onference session and webcast will be audio only a...ray will host a webcast of the presentation live a...
(Date:11/20/2009)...0 BD (Becton, Dickinson ...mpletion of its acquisition of HandyLab, Inc., an ...d manufactures molecular diagnostic assays and aut...Lab announced an exclusive agreement for BD to dev...dyLab Jaguar(TM) platform, the first fully integra...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bull...erly known as DOR BioPharma, Inc., a late-stage bi...ormed a consortium to develop thermostable technol...vaccines. Soligenix received a $9.4 million grant ...ous Diseases (NIAID), a division of the National I...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 1Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 2Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 3Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 4Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 1Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 2Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 3Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 4Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 5Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 6Torn Surgical Gloves Put Patients at Risk for Infection 49069 1Torn Surgical Gloves Put Patients at Risk for Infection 49069 2
...t fails to mention ongoing FDA-approved HIFU clini...nical data on HIFU outcomes and experience, CHARL...stributor of the minimally invasive Sonablate(R) 5...h America, announced that the June 16, 2008,editio... intensity focused,ultrasound (HIFU) for treating ...
...ubmission Based on Data from Placebo-Controlled Ph...tients in a Randomized Study, WOODCLIFF LAKE, N.J...ounced today that the U.S. Food and Drug Administr...plemental biologics license,application (sBLA) for...d,approval indication into full approval. It is ba...
Other Medicine Technology:ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer 2ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer 3FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 2FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 3FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 4FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 5
...Drug Screen Tests are available in 14 configuratio...Designed using Microgenics Antibody Technology, th...point of care immunoassay targeted to detect MDMA ...cross-reactivity to any isomer of methamphetamine ...
...ite test! QuickScreen™ multi-panel dip cards...our choice of any conceivable combination of 9 dif...r total flexibility for your drug testing program....-in timer tells you when to read the results. Our ...
Insure
...tely 500,000 people die each year of colon cancer ...mprovements (high contrast berium enema, colonosco...e in the success rate of curative treatment for co... past two decades. The chances of successful treat...
Medicine Products: